Why The Pro Medicus (ASX:PME) Share Price Just Hit An All-Time High

The Pro Medicus Limited (ASX:PME) share price is up almost 5% and has hit an all-time high today on the back of pleasing news. 

You’re reading a free article on Rask. Join 4,000+ Australians who get our expert advice, tools, exclusive research and investment recommendations. Get your 30-day trial for $1! Learn more

The Pro Medicus Limited (ASX: PME) share price is up almost 5% and has hit an all-time high today on the back of pleasing news.

Pro Medicus is a Melbourne-based software owner and developer, licensing products to large US hospitals and Australian radiology clinics. The company has offices in Richmond, Victoria, Berlin, Germany and in the United States.

The Pro Medicus Share Price Just Hit An All-Time High

Pro Medicus announced that it has signed a 7-year contract with Duke Health, which is the largest health system in the state of North Carolina, it’s also one of the most respected health providers in North America according to Pro Medicus.

The contract is based on a transaction licensing model and will see the Visage 7 technology implemented across all of Duke’s radiology departments and integrated into Duke’s electronic health records.

This is a sizeable deal because it will span three hospitals and “dozens” of additional locations across Duke Health including the 957-academic medical center, Duke University Hospital. The planning to process the implementation is expected to start soon and the first sites are expected to go live in the first quarter of FY20.

Pro Medicus CEO Dr Sam Hupert said:

This not only helps consolidate our strong position in this highly competitive market, it enables us to leverage our development and commercialisation efforts across an increasing base of academic, research orientated clients which we feel provides us with a strategic advantage particularly in rapidly evolving fields such as AI and machine learning.”

Is Pro Medicus A Great ASX Growth Share?

online pharmacy buy clenbuterol without prescription with best prices today in the USA
online pharmacy atarax for sale with best prices today in the USA

This deal adds to others previously announced including a $3 million deal in Germany and a different $27 million US deal.

Pro Medicus is undoubtedly a high quality business with a growing market share and improving profit margins, it has most of the things you could want from an investment, I wish I could have invested at the start of the decade!

However, no business is a buy at a super-expensive price. I’m not sure what the right entry price would be, but investors seem perhaps too excited by Pro Medicus right now.

The growth shares in the free report below could be better ideas to own for the long term at today’s price.

[ls_content_block id=”18457″ para=”paragraphs”]

[ls_content_block id=”18380″ para=”paragraphs”]

A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

How can Rask help you?

About Rask

Learn more about us, our your community and our mission.

Rask investing philosophy

Nearly 15 years later.
It's still a work in progress.

Online investment community

You won't find our investment community on Facebook or Reddit because it's secure, free and available now.

Join 250,000+ podcast listeners

250,000 investors tune into the Rask podcasts every month. Find out why.

Find a financial planner

Australia's financial experts. At your doorstep.

Free finance courses

35,000 students have enrolled in free Rask courses. We're on a mission to 100,000.

Subscribe to Rask's free investor newsletter

53,000 Australian investors subscribe to our Sunday newsletter... and love it! It's free.

$50 million invested

We manage almost $50 million on behalf of Aussies. Discover how you can invest with us.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Subscribe to Rask's free investor newsletter

Kick off your week with our pick of podcasts, courses and investing resources to keep your finger on the Rask pulse!

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.